Karen L Saban1, Herbert L Mathews2, Holli A DeVon3, Linda W Janusek4. 1. Marcella Niehoff School of Nursing, Loyola University Chicago, Maywood, IL, USA ; Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. VA Hospital, Hines, IL, USA. 2. Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA. 3. College of Nursing, University of Illinois at Chicago, Chicago, IL, USA. 4. Marcella Niehoff School of Nursing, Loyola University Chicago, Maywood, IL, USA.
Abstract
BACKGROUND: Although it is well established that African Americans (AA) experience greater social stressors than non-Hispanic Whites (NHW), the extent to which early life adversity and cumulative social stressors such as perceived discrimination, neighborhood violence, subjective social status, and socioeconomic status contribute to disparity in coronary heart disease (CHD) and stroke between AA and NHW are not well understood. PURPOSE: The purpose of this paper is to propose a conceptual model based upon McEwen's Allostatic Load Model suggesting how the relationships among social context, early life adversity, psychological stress, inflammation, adaptation, and epigenetic signature may contribute to the development of CHD and ischemic stroke. We hypothesize that social context and prior life adversity are associated with genome-wide as well as gene-specific epigenetic modifications that confer a proinflammatory epigenetic signature that mediates an enhanced proinflammatory state. Exposure to early life adversity, coupled with an increased allostatic load places individuals at greater risk for inflammatory based diseases, such as CHD and ischemic stroke. RESULTS: Based on a review of the literature, we propose a novel model in which social context and psychological stress, particularly during early life, engenders a proinflammatory epigenetic signature, which drives a heightened inflammatory state that increases risk for CHD and stroke. In the proposed model, a proinflammatory epigenetic signature and adaptation serve as mediator variables. CONCLUSIONS: Understanding the extent to which epigenetic signature bridges the psycho-social environment with inflammation and risk for CHD may yield novel biomarkers that can be used to assess risk, development, and progression of CHD/stroke. Epigenetic biomarkers may be used to inform preventive and treatment strategies that can be targeted to those most vulnerable, or to those with early signs of CHD, such as endothelial dysfunction. Furthermore, epigenetic approaches, including lifestyle modification and stress reduction programs, such as mindfulness-based stress reduction, offer promise to reduce health inequity linked to social disadvantage, as emerging evidence demonstrates that adverse epigenetic marks can be reversed.
BACKGROUND: Although it is well established that African Americans (AA) experience greater social stressors than non-Hispanic Whites (NHW), the extent to which early life adversity and cumulative social stressors such as perceived discrimination, neighborhood violence, subjective social status, and socioeconomic status contribute to disparity in coronary heart disease (CHD) and stroke between AA and NHW are not well understood. PURPOSE: The purpose of this paper is to propose a conceptual model based upon McEwen's Allostatic Load Model suggesting how the relationships among social context, early life adversity, psychological stress, inflammation, adaptation, and epigenetic signature may contribute to the development of CHD and ischemic stroke. We hypothesize that social context and prior life adversity are associated with genome-wide as well as gene-specific epigenetic modifications that confer a proinflammatory epigenetic signature that mediates an enhanced proinflammatory state. Exposure to early life adversity, coupled with an increased allostatic load places individuals at greater risk for inflammatory based diseases, such as CHD and ischemic stroke. RESULTS: Based on a review of the literature, we propose a novel model in which social context and psychological stress, particularly during early life, engenders a proinflammatory epigenetic signature, which drives a heightened inflammatory state that increases risk for CHD and stroke. In the proposed model, a proinflammatory epigenetic signature and adaptation serve as mediator variables. CONCLUSIONS: Understanding the extent to which epigenetic signature bridges the psycho-social environment with inflammation and risk for CHD may yield novel biomarkers that can be used to assess risk, development, and progression of CHD/stroke. Epigenetic biomarkers may be used to inform preventive and treatment strategies that can be targeted to those most vulnerable, or to those with early signs of CHD, such as endothelial dysfunction. Furthermore, epigenetic approaches, including lifestyle modification and stress reduction programs, such as mindfulness-based stress reduction, offer promise to reduce health inequity linked to social disadvantage, as emerging evidence demonstrates that adverse epigenetic marks can be reversed.
Entities:
Keywords:
Cardiovascular Disease; Cytokines; Epigenetics; Epigenomics; Health Status Disparities; Stroke
Authors: Salvador Cruz-Flores; Alejandro Rabinstein; Jose Biller; Mitchell S V Elkind; Patrick Griffith; Philip B Gorelick; George Howard; Enrique C Leira; Lewis B Morgenstern; Bruce Ovbiagele; Eric Peterson; Wayne Rosamond; Brian Trimble; Amy L Valderrama Journal: Stroke Date: 2011-05-26 Impact factor: 7.914
Authors: Nikolaos P Daskalakis; Rosemary C Bagot; Karen J Parker; Christiaan H Vinkers; E R de Kloet Journal: Psychoneuroendocrinology Date: 2013-07-07 Impact factor: 4.905
Authors: H-X Wang; C Leineweber; R Kirkeeide; B Svane; K Schenck-Gustafsson; T Theorell; K Orth-Gomér Journal: J Intern Med Date: 2007-03 Impact factor: 8.989
Authors: Chris J Packard; Vladimir Bezlyak; Jennifer S McLean; G David Batty; Ian Ford; Harry Burns; Jonathan Cavanagh; Kevin A Deans; Marion Henderson; Agnes McGinty; Keith Millar; Naveed Sattar; Paul G Shiels; Yoga N Velupillai; Carol Tannahill Journal: BMC Public Health Date: 2011-01-17 Impact factor: 3.295
Authors: May A Beydoun; Angedith Poggi-Burke; Alan B Zonderman; Ola S Rostant; Michele K Evans; Deidra C Crews Journal: Psychosom Med Date: 2017-09 Impact factor: 4.312
Authors: Carmen Giurgescu; Alexandra L Nowak; Shannon Gillespie; Timiya S Nolan; Cindy M Anderson; Jodi L Ford; Daryl B Hood; Karen Patricia Williams Journal: J Urban Health Date: 2019-03 Impact factor: 3.671